FDA Panel Supports Cymbalta for Chronic Pain
August 19th, 2010
An FDA advisory panel gave a closely divided vote of support to drugmaker Eli Lilly’s application to increase the number of approved uses for one of its best-selling drugs, the antidepressant Cymbalta.
Originally posted here:
FDA Panel Supports Cymbalta for Chronic Pain
Recent Comments